Susquehanna International Group’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-324,281
| Closed | -$57.4M | – | 11463 |
|
|
2020
Q1 | $57.4M | Sell |
324,281
-182,559
| -36% | -$34.4M | 0.02% | 593 |
|
|
2019
Q4 | $96.9M | Sell |
506,840
-109,876
| -18% | -$19.8M | 0.03% | 501 |
|
|
2019
Q3 | $104M | Sell |
616,716
-808,958
| -57% | -$132M | 0.03% | 428 |
|
|
2019
Q2 | $239M | Buy |
1,425,674
+790,168
| +124% | +$109M | 0.09% | 187 |
|
|
2019
Q1 | $93M | Buy |
635,506
+234,564
| +59% | +$34M | 0.04% | 390 |
|
|
2018
Q4 | $53.6M | Buy |
400,942
+287,980
| +255% | +$47.2M | 0.02% | 579 |
|
|
2018
Q3 | $21.5M | Sell |
112,962
-833,446
| -88% | -$153M | 0.01% | 1271 |
|
|
2018
Q2 | $158M | Sell |
946,408
-448,305
| -32% | -$72M | 0.05% | 289 |
|
|
2018
Q1 | $235M | Sell |
1,394,713
-276,246
| -17% | -$46.3M | 0.08% | 190 |
|
|
2017
Q4 | $273M | Buy |
1,670,959
+647,713
| +63% | +$116M | 0.1% | 176 |
|
|
2017
Q3 | $210M | Buy |
1,023,246
+921,341
| +904% | +$214M | 0.08% | 203 |
|
|
2017
Q2 | $24.8M | Buy |
101,905
+35,996
| +55% | +$8.46M | 0.01% | 997 |
|
|
2017
Q1 | $15.7M | Buy |
65,909
+41,509
| +170% | +$9.67M | 0.01% | 1260 |
|
|
2016
Q4 | $5.12M | Sell |
24,400
-502,498
| -95% | -$104M | ﹤0.01% | 2403 |
|
|
2016
Q3 | $121M | Sell |
526,898
-162,585
| -24% | -$39.7M | 0.06% | 286 |
|
|
2016
Q2 | $159M | Buy |
689,483
+128,274
| +23% | +$29.6M | 0.09% | 199 |
|
|
2016
Q1 | $150M | Sell |
561,209
-694,296
| -55% | -$199M | 0.08% | 202 |
|
|
2015
Q4 | $392M | Buy |
1,255,505
+687,371
| +121% | +$205M | 0.18% | 93 |
|
|
2015
Q3 | $154M | Buy |
568,134
+270,320
| +91% | +$83M | 0.07% | 249 |
|
|
2015
Q2 | $90.4M | Sell |
297,814
-348,185
| -54% | -$104M | 0.04% | 447 |
|
|
2015
Q1 | $192M | Buy |
645,999
+336,162
| +108% | +$95.8M | 0.09% | 206 |
|
|
2014
Q4 | $79.8M | Sell |
309,837
-215,313
| -41% | -$53.8M | 0.03% | 505 |
|
|
2014
Q3 | $127M | Buy |
525,150
+273,719
| +109% | +$61.3M | 0.05% | 344 |
|
|
2014
Q2 | $56.1M | Buy |
251,431
+185,039
| +279% | +$38.3M | 0.02% | 636 |
|
|
2014
Q1 | $13.7M | Sell |
66,392
-61,268
| -48% | -$12.1M | 0.01% | 1658 |
|
|
2013
Q4 | $21.4M | Sell |
127,660
-162,183
| -56% | -$25.4M | 0.01% | 1286 |
|
|
2013
Q3 | $41.7M | Sell |
289,843
-31,958
| -10% | -$4.26M | 0.02% | 687 |
|
|
2013
Q2 | $40.6M | Buy |
+321,801
| New | +$36.4M | 0.02% | 656 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Susquehanna International Group's AGN Position: Q2 2020 in Review
Susquehanna International Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 324,281 shares — an estimated $57.4M sold.
Susquehanna International Group first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $392M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Susquehanna International Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Susquehanna International Group sold 324,281 Allergan plc shares in Q2 2020, an estimated $57.4M.
- Susquehanna International Group first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Susquehanna International Group's Allergan plc position peaked at $392M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.